| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Feb―18 |
Activation of the interferon pathway in trophoblast cells productively infected with SARS-CoV-2 |
Sampada Kallol, Laura Martin-Sancho, Robert Morey, Omonigho Aisagbonhi, Donald Pizzo, Morgan Meads, Sumit K Chanda, Francesca Soncin |
| 2 |
[GO] |
2021―Aug―21 |
Research status of the safety and efficacy of mesenchymal stem cells in the treatment of COVID-19-related pneumonia: A systematic review and meta-analysis |
Junwu Wang, Pengzhi Shi, Dong Chen, Shuguang Wang, Pingchuan Wang, Xinmin Feng, liang zhang |
| 3 |
[GO] |
2021―Jun―02 |
Wharton’s Jelly Mesenchymal Stem Cell-derived Extracellular Vesicles Reduce SARS-CoV2 Induced Inflammatory Cytokines under High Glucose and Uremic Toxin Conditions |
Vuong Cat Khanh, Mizuho Fukushige, Yun-Hsuan Chang, Ngo Nhat Hoang, Toshiharu Yamashita, Mana Obata-Yasuoka, Hiromi Hamada, Motoo Osaka, Yuji Hiramatsu, Osamu Ohneda |
| 4 |
[GO] |
2021―May―28 |
Human umbilical cord mesenchymal stromal cell treatment of severe COVID-19 patients: a three-month follow-up study following hospital discharge |
Ganzhu Feng, Lei Shi, Tingrong Huang, Ningfei Ji, You Zheng, Huan Lin, Changming Niu, Yan Wang, Ruyou Li, Mao Huang, Xiaolin Chen, Lei Shu, Mingjing Wu, Kaili Deng, Jing Wei, Xueli Wang, Yang Cao, Jiaxin Yan |
| 5 |
[GO] |
2021―Mar―15 |
Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19 |
Qiqi Cai, Fei Yin, Liming Hao, Wen-Hua Jiang |
| 6 |
[GO] |
2020―Dec―14 |
The coronavirus pandemic: a pitfall or a fast-track for validating cell therapy products? |
maroun khoury, Laertis Ikonomou, massimo Dominici, Katarina Le Blanc, Bruce L Levine, Dan J Weiss |
| 7 |
[GO] |
2020―Sep―01 |
Human induced pluripotent stem cell-derived lung epithelial system for SARS-CoV-2 infection modeling and its potential in drug repurposing |
Harshini Surendran, Swapna Nandakumar, Rajarshi Pal |
| 8 |
[GO] |
2020―Jun―10 |
Response to Kim et al. re: “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19” |
Vikram Sengupta, Sascha Sengupta, Angel Lazo, Kevin C. Hicok, Timothy Moseley |
| 9 |
[GO] |
2020―Jun―10 |
Re: “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19” by Sengupta et al. |
Sai Kiang Lim, Bernd Giebel, Daniel J. Weiss, Kenneth W. Witwer, Eva Rohde |
| 10 |
[GO] |
2020―May―08 |
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19 |
Vikram Sengupta, Sascha Sengupta, Angel Lazo, Peter Woods, Anna Nolan, Nicholas Bremer |
| 11 |
[GO] |
2020―Apr―15 |
Stem cell-based therapy for coronavirus disease 2019 |
Robert Chunhua Zhao |
| 12 |
[GO] |
2020―Apr―02 |
Impact of COVID-19 and Future Emerging Viruses on Hematopoietic Cell Transplantation and Other Cellular Therapies |
Hal E. Broxmeyer, Graham C. Parker |
|
